Single domain antibodies capable of modulating bace activity

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 16/40 (2006.01) C12N 9/64 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2720013

The present invention relates to single domain antibodies with a specificity for BACE1. More specifically, the invention provides single variable domain antibodies derived from camelids which bind to BACE1 and are capable of inhibiting the activity of BACE1. Said antibodies can be used for research and medical applications. Specific applications include the use of BACE1 specific antibodies for the treatment of Alzheimer's disease.

La présente invention porte sur des anticorps à domaine unique avec une spécificité pour la BACE1. Plus spécifiquement, l'invention porte sur des anticorps à domaine variable unique issus de camélides qui se lient à la BACE1 et sont capables d'inhiber l'activité de la BACE1. Lesdits anticorps peuvent être utilisés pour des applications de recherche et médicales. Des applications spécifiques comprennent l'utilisation d'anticorps spécifiques de la BACE1 pour le traitement de la maladie d'Alzheimer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Single domain antibodies capable of modulating bace activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Single domain antibodies capable of modulating bace activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single domain antibodies capable of modulating bace activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1740164

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.